Average Co-Inventor Count = 3.21
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Idera Pharmaceuticals, Inc. (9 from 80 patents)
2. Hybridon, Inc. (6 from 98 patents)
15 patents:
1. 8716253 - Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
2. 8476416 - Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
3. 8030462 - Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
4. 7932367 - Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
5. 7833538 - Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
6. 7824696 - Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
7. 7790168 - Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
8. 7700570 - Oligonucleotide mediated specific cytokine induction and prophylaxis and treatment of viral infection in a mammal
9. 7262286 - Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
10. 6667293 - Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response
11. 6426334 - Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
12. 5968909 - Method of modulating gene expression with reduced immunostimulatory
13. 5691316 - Cyclodextrin cellular delivery system for oligonucleotides
14. 5616565 - Cyclodextrin cellular delivery system for oligonucleotides
15. 5605890 - Cyclodextrin cellular delivery system for oligonucleotides